Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project.
Behavioral disturbances
dementia
special care units
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
16
3
2021
medline:
18
9
2021
entrez:
15
3
2021
Statut:
ppublish
Résumé
Behavioral and psychological symptoms of dementia (BPSD) are quite challenging problems during the dementia course. Special Care Units for people with dementia (PwD) and BPSD (SCU-B) are residential medical structures, where BPSD patients are temporarily admitted, in case of unmanageable behavioral disturbances at home. RECage (REspectful Caring for AGitated Elderly) aspires to assess the short and long-term effectiveness of SCU-Bs toward alleviating BPSD and improving the quality of life (QoL) of PwD and their caregivers. RECage is a three-year, prospective study enrolling 500 PwD. Particularly, 250 community-dwelling PwDs presenting with severe BPSD will be recruited by five clinical centers across Europe, endowed with a SCU-B, for a short period of time; a second similar group of 250 PwD will be followed by six other no-SCU-B centers solely via outpatient visits. RECage's endpoints include short and long-term SCU-B clinical efficacy, QoL of patients and caregivers, cost-effectiveness of the SCU-B, psychotropic drug consumption, caregivers' attitude toward dementia, and time to nursing home placement. PwD admitted in SCU-Bs are expected to have diminished rates of BPSD and better QoL and their caregivers are also expected to have better QoL and improved attitude towards dementia, compared to those followed in no-SCU-Bs. Also, the cost of care and the psychotropic drug consumption are expected to be lower. Finally, PwD followed in no-SCU-Bs are expected to have earlier admission to nursing homes. The cohort study results will refine the SCU-B model, issuing recommendations for implementation of SCU-Bs in the countries where they are scarce or non-existent.
Sections du résumé
BACKGROUND
Behavioral and psychological symptoms of dementia (BPSD) are quite challenging problems during the dementia course. Special Care Units for people with dementia (PwD) and BPSD (SCU-B) are residential medical structures, where BPSD patients are temporarily admitted, in case of unmanageable behavioral disturbances at home.
OBJECTIVE
RECage (REspectful Caring for AGitated Elderly) aspires to assess the short and long-term effectiveness of SCU-Bs toward alleviating BPSD and improving the quality of life (QoL) of PwD and their caregivers.
METHODS
RECage is a three-year, prospective study enrolling 500 PwD. Particularly, 250 community-dwelling PwDs presenting with severe BPSD will be recruited by five clinical centers across Europe, endowed with a SCU-B, for a short period of time; a second similar group of 250 PwD will be followed by six other no-SCU-B centers solely via outpatient visits. RECage's endpoints include short and long-term SCU-B clinical efficacy, QoL of patients and caregivers, cost-effectiveness of the SCU-B, psychotropic drug consumption, caregivers' attitude toward dementia, and time to nursing home placement.
RESULTS
PwD admitted in SCU-Bs are expected to have diminished rates of BPSD and better QoL and their caregivers are also expected to have better QoL and improved attitude towards dementia, compared to those followed in no-SCU-Bs. Also, the cost of care and the psychotropic drug consumption are expected to be lower. Finally, PwD followed in no-SCU-Bs are expected to have earlier admission to nursing homes.
CONCLUSION
The cohort study results will refine the SCU-B model, issuing recommendations for implementation of SCU-Bs in the countries where they are scarce or non-existent.
Identifiants
pubmed: 33720887
pii: JAD201215
doi: 10.3233/JAD-201215
pmc: PMC8203243
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1613-1627Commentaires et corrections
Type : ErratumIn
Références
Arch Gerontol Geriatr. 2007;44 Suppl 1:113-20
pubmed: 17317443
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9
pubmed: 9236950
Nurs Outlook. 2017 Sep - Oct;65(5):515-529
pubmed: 28826872
J Neurol. 2019 Oct;266(10):2363-2375
pubmed: 30666436
Int J Geriatr Psychiatry. 2006 Oct;21(10):972-6
pubmed: 16955429
Behav Brain Res. 2020 Jul 15;390:112617
pubmed: 32428636
Int Psychogeriatr. 2010 May;22(3):346-72
pubmed: 20096151
Curr Neuropharmacol. 2016;14(4):307-13
pubmed: 26644152
Clin Nurs Res. 2019 Jan;28(1):9-29
pubmed: 29441797
Psychopharmacology (Berl). 2010 Oct;212(2):119-29
pubmed: 20661553
Clin Gerontol. 2019 Nov 22;:1-21
pubmed: 31752633
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Am J Geriatr Psychiatry. 2011 Feb;19(2):160-8
pubmed: 20808116
Int J Geriatr Psychiatry. 2012 Aug;27(8):844-53
pubmed: 21956773
Dementia (London). 2018 Feb;17(2):227-233
pubmed: 26984130
Health Technol Assess. 2014 Jun;18(39):1-226, v-vi
pubmed: 24947468
Psychogeriatrics. 2019 Jul;19(4):310-319
pubmed: 30723980
J Altern Complement Med. 2016 Jun;22(6):422-8
pubmed: 27159213
Eur J Neurol. 2020 Oct;27(10):1805-1820
pubmed: 32713125
Int J Geriatr Psychiatry. 2004 Jun;19(6):527-32
pubmed: 15211530
Rev Neurol (Paris). 2011 Mar;167(3):254-9
pubmed: 20947112
Funct Neurol. 2018 Jul/Sept;33(3):143-147
pubmed: 30457967
Int J Nurs Stud. 2015 May;52(5):980-7
pubmed: 25776735
Am J Geriatr Psychiatry. 2017 Oct;25(10):1074-1082
pubmed: 28754586
Am J Psychiatry. 2012 Sep;169(9):900-6
pubmed: 22952071
Eur Neuropsychopharmacol. 2014 Nov;24(11):1729-37
pubmed: 25453487
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
J Clin Nurs. 2016 Jul;25(13-14):1805-34
pubmed: 27030571
J Am Geriatr Soc. 2014 Apr;62(4):762-9
pubmed: 24635665
J Affect Disord. 2016 Jan 15;190:264-271
pubmed: 26540080
Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):490-4
pubmed: 23523558
Sleep Med Rev. 2020 Aug;52:101310
pubmed: 32289734
Int Psychogeriatr. 2005 Dec;17(4):577-89
pubmed: 16185379
Am J Psychiatry. 2000 May;157(5):708-14
pubmed: 10784462
Int J Geriatr Psychiatry. 2017 Jan;32(1):76-85
pubmed: 26891463
J Alzheimers Dis. 2018;62(1):99-113
pubmed: 29439334
Health Qual Life Outcomes. 2016 Jun 14;14:90
pubmed: 27301257
Am Fam Physician. 2016 Aug 15;94(4):276-82
pubmed: 27548592
Gerontologist. 2018 Jan 18;58(suppl_1):S10-S19
pubmed: 29361064
BMJ. 2015 Mar 02;350:h369
pubmed: 25731881
Int J Geriatr Psychiatry. 2019 Oct;34(10):1378-1385
pubmed: 31025764
Prof Inferm. 2013 Jan-Mar;66(1):39-47
pubmed: 23591035
Dement Geriatr Cogn Disord. 2015;40(5-6):268-75
pubmed: 26302667
Neurology. 1997 May;48(5 Suppl 6):S10-6
pubmed: 9153155
Transl Psychiatry. 2017 Oct 31;7(10):e1250
pubmed: 29087372
J Alzheimers Dis. 2014;42(3):915-37
pubmed: 25024323
Dement Geriatr Cogn Dis Extra. 2017 Nov 1;7(3):354-365
pubmed: 29282408
Neuropsychol Rev. 2018 Dec;28(4):393-416
pubmed: 30536144
Curr Alzheimer Res. 2012 Jul;9(6):759-71
pubmed: 22715983
Am J Psychiatry. 2016 May 1;173(5):543-6
pubmed: 27133416
Soc Sci Med. 2008 Sep;67(5):874-82
pubmed: 18572295
Aging Ment Health. 2019 Oct;23(10):1442-1450
pubmed: 30474401
Ageing Res Rev. 2012 Jan;11(1):78-86
pubmed: 21856452
JAMA. 2012 Nov 21;308(19):2020-9
pubmed: 23168825
Alzheimer Dis Assoc Disord. 1997 Mar;11(1):53-6
pubmed: 9071445
Dement Geriatr Cogn Disord. 2008;25(3):272-7
pubmed: 18285675
Gerontologist. 1989 Dec;29(6):798-803
pubmed: 2516000
Psychother Psychosom. 2007;76(4):226-33
pubmed: 17570961
Psychogeriatrics. 2018 Sep;18(5):327-333
pubmed: 29987904
Front Neurol. 2012 May 07;3:73
pubmed: 22586419
J Adv Nurs. 2017 Oct;73(10):2283-2295
pubmed: 28378347
Consult Pharm. 2017 Oct 1;32(10):623-628
pubmed: 28992823